Back to Search
DIONISIA KATSAROS, PHARMD
PHARMD
Pharmacist
NPI: 1023612041Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
PH237249(MA)
Research & Publications (20)
Peptide concentrations and mRNA expression of IGF-I, IGF-II and IGFBP-3 in breast cancer and their associations with disease characteristics.
PMID 18481170·Breast Cancer Res Treat·2009
8-other
A phase II, randomized trial of neo-adjuvant chemotherapy comparing a three-drug combination of paclitaxel, ifosfamide, and cisplatin (TIP) versus paclitaxel and cisplatin (TP) followed by radical surgery in patients with locally advanced squamous cell cervical carcinoma: the Snap-02 Italian Collaborative Study.
PMID 19181826·Ann Oncol·2009
3-trial
Epithelial-mesenchymal transition of ovarian tumor cells induces an angiogenic monocyte cell population.
PMID 19538958·Exp Cell Res·2009
8-other
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
PMID 19172191·PLoS One·2009
7-preclinical
Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II.
PMID 19477633·Eur J Cancer·2009
8-other
Poor outcome of elderly patients with platinum-sensitive recurrent ovarian cancer: results from the SOCRATES retrospective study.
PMID 19179095·Crit Rev Oncol Hematol·2009
8-other
High miR-21 expression in breast cancer associated with poor disease-free survival in early stage disease and high TGF-beta1.
PMID 18932017·Breast Cancer Res Treat·2009
8-other
Weekly low-dose paclitaxel as maintenance treatment in patients with advanced ovarian cancer who had microscopic residual disease at second-look surgery after 6 cycles of paclitaxel/platinum-based chemotherapy: results of an open noncomparative phase 2 multicenter Italian study (After-6 Protocol 2).
PMID 19509559·Int J Gynecol Cancer·2009
3-trial
Stathmin and tubulin expression and survival of ovarian cancer patients receiving platinum treatment with and without paclitaxel.
PMID 19322891·Cancer·2009
8-other
Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer.
PMID 18458333·Proc Natl Acad Sci U S A·2008
8-other
Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study.
PMID 18761742·BMC Cancer·2008
8-other
The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis.
PMID 18193036·Nat Cell Biol·2008
7-preclinical
TGF-beta1 genotype and phenotype in breast cancer and their associations with IGFs and patient survival.
PMID 18827819·Br J Cancer·2008
8-other
A gene expression signature that can predict the recurrence of tamoxifen-treated primary breast cancer.
PMID 18347175·Clin Cancer Res·2008
4-observational
Transcriptional regulation of PIK3CA oncogene by NF-kappaB in ovarian cancer microenvironment.
PMID 18335034·PLoS One·2008
8-other
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer.
PMID 18281662·J Clin Oncol·2008
3-trial
Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial.
PMID 19033573·J Natl Cancer Inst·2008
4-observational
Klotho expression in epithelial ovarian cancer and its association with insulin-like growth factors and disease progression.
PMID 18259951·Cancer Invest·2008
8-other
MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer.
PMID 19074899·Cancer Res·2008
8-other
Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.
PMID 18157142·Nat Med·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 203 LINDEN PONDS WAY
HINGHAM, MA 02043 - Phone
- (781) 534-7270
Quick Facts
- NPI
- 1023612041
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile